Medical/Pharmaceuticals

The 20th CACLP & 3rd CISCE Closed with Record-breaking Numbers in Nanchang

NANCHANG, China, June 12, 2023 /PRNewswire/ -- From 28 to 30 May 2023, the 20th China Association of Clinical Laboratory Practice Expo (CACLP) and the 3rd China IVD Supply Chain Expo (CISCE), recognized as the world's leading in vitro diagnostics (IVD) exhibition, were successfully closed inNanch...

2023-06-12 18:45 4289

Taipei Entrepreneurs Hub Focuses on the Greater Health Industries, Taipei City Government Facilitates Global Talents Matchmaking

TAIPEI, June 12, 2023 /PRNewswire/ -- The Taipei City Government continues to promote the "Talent Exchange Program" in support of international entrepreneurs collaborating with companies inTaipei. Serving as the international startup community brand, Taipei Entrepreneurs Hub (TEH) is set to kick ...

2023-06-12 16:12 3444

Innovent Announces Phase 1 Clinical Data of IBI322 (CD47/PD-L1 Bispecific Antibody) in the Treatment of Anti-PD-(L)1-resistant Classic Hodgkin Lymphoma Patients at the EHA 2023 Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, June 12, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology an...

2023-06-12 08:00 7451

DxVx, won the governmental project to develop diagnostic sensor kit for adult diseases

* National Project converging semiconductor and biotechnology SEOUL, South Korea, June 9, 2023 /PRNewswire/ -- DxVx announced today that it won the national project, 'Korea-led K-Sensor Technology Development for Market Leadership' supported by the Ministry of Trade, Industry and Energy and man...

2023-06-09 21:00 6107

Treating COVID with Metformin Reduces Long COVID Rates

MINNEAPOLIS, June 9, 2023 /PRNewswire/ -- A new study published in The Lancet Infectious Diseasessupported by the Parsemus Foundation found a 41% reduction in Long COVID rates among people who used metformin at the time of COVID infection. The trial also saw a 42% reduction in emergency room visi...

2023-06-09 21:00 6612

Anti-Aging and Reproductive Medical Giants Gathered in Hong Kong Dragon's Medical Led Chinese Medical Development

HONG KONG, June 9, 2023 /PRNewswire/ -- Dragon's Medical successfully held its Advance Medical Technology Press Conference 2023 atW Hong Kong today, signing strategic partnership agreements with various medical groups fromMainland China, Hong Kong and Taiwan, deepening their long-term strategic pa...

2023-06-09 13:00 3078

China Approves the World's First Vaccine against XBB Descendent Lineages of SARS-CoV-2 for Emergency Use

CHENGDU, China, June 9, 2023 /PRNewswire/ -- On June 8th, 2023, Coviccine® Trivalent XBB.1.5-Recombinant COVID-19 Trivalent (XBB.1.5+BA.5+Delta) Protein Vaccine (Sf9 cell) developed by WestVac Biopharma/ West China Medical Center, Sichuan University was approved for EUA by relevant authorities in ...

2023-06-09 11:59 5709

Investor Open Day: Fosun Implements Business Streamlining and Resilience Building Strategy, Focusing on Core Businesses to Bring New Vitality

HONG KONG, June 9, 2023 /PRNewswire/ -- On 8 June 2023, the 2023 Fosun International Investor Open Day was held inShanghai. It was the first time that Fosun International had held a large-scale offline open day after the pandemic. More than 100 domestic and foreign investor representatives from B...

2023-06-09 11:16 6548

LTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business

ANDERNACH, Germany, June 8, 2023 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS"), Oral Thin Films ("OTF") and Micro Array Patches ("MAP") has co...

2023-06-08 23:00 3485

DNAnexus® Applauded by Frost & Sullivan for Supporting Better Clinical Decision-making and More Effective Therapies

Since 2013, DNAnexus has led the market in cloud computing and bioinformatics platforms that handle complex data processing for genomics and multi-omics, counting more than 100 enterprise customers worldwide. SAN ANTONIO, June 8, 2023 /PRNewswire/ -- Frost & Sullivan's recent analysis of the pre...

2023-06-08 20:00 3259

Telix Opens European Radiopharmaceutical Production Facility

* Telix has unveiled its new, state-of-art radiopharmaceutical facility in Brussels South as part of its first stage investment of €14.1 million ($A21.2 million)    * Located in Walloon's 'Radiopharma Valley' the facility will be a central hub for research and development for the region and f...

2023-06-08 20:00 3970

Qilu Pharmaceutical Announces Trials in Progress Posters on QL1706 in Phase III NSCLC Clinical Research at ASCO 2023

JINAN, China, June 8, 2023 /PRNewswire/ -- Recently, Qilu Pharmaceutical presented a Trials in Progress poster presentation on QL1706 (iparomlimab/tuvonralimab), an innovative bifunctional antibody for immunotherapy, in two Phase III non-small cell lung carcinoma (NSCLC) clinical studies at the ...

2023-06-08 15:35 2985

Generative Artificial Intelligence Tools Empowering Scientific Publications: Turacoz's Contribution to Medical Writing Industry

UTRECHT, Netherlands and NEW DELHI, June 7, 2023 /PRNewswire/ -- Turacoz embraces the transformative impact of generative AI in medical communications by actively participating in relevant events with both newcomers and professionals in the field. Recently, Dr.Namrata Singh, Founder and Director,...

2023-06-07 21:50 4795

NEC Thailand and Chiang Mai Municipality trial digital health platform to support elderly and patient care in Chiang Mai

CHIANG MAI, Thailand, June 7, 2023 /PRNewswire/ -- NEC Corporation (Thailand) Ltd. (NEC Thailand), has signed a Memorandum of Understanding (MoU) with Chiang Mai Municipality to develop smart city solutions and transformChiang Mai into a smart city, starting with a digital platform for the distri...

2023-06-07 17:30 3829

ACROBiosystems expands custom GMP-grade protein services to drive CGT development and commercialization

TOKYO, June 7, 2023 /PRNewswire/ -- Cell and gene therapy (CGT) is a cutting-edge therapy that combats cancer by bolstering the immune system through stem cell infusions or modified immune cells. However, manufacturing cell therapies isno easy feat. To support the commercialization of cell thera...

2023-06-07 16:05 3807

Gencurix Announces Clinical Research Results At ASCO Demonstrating Outstanding Performance of GenesWellBCT Compared to Global Best-Selling Test, OncotypeDX

SEOUL, South Korea, June 7, 2023 /PRNewswire/ -- Gencurix an nounced the release of clinical research results comparing the accuracy of its breast cancer prognostic test, GenesWellBCT, with OncotypeDX, the globally top-s...

2023-06-07 12:29 4078

BetaLife wins Cytiva's first BioChallenge Competition in Southeast Asia

* BetaLife wins top prize with its potential to provide regenerative medicines to patients with severe diabetes inSoutheast Asia. * Cytiva's BioChallenge aims to support the innovation of biotech startups. Singapore, June 7, 2023 /PRNewswire/ -- Cytiva recognizes the talent, resource and scal...

2023-06-07 12:00 3607

First Medical Product in New Hybrid Light-Curable Adhesive Platform from Dymax

Offers Rapid Curing in Light or Darkness to a Wider Range of Substrates SINGAPORE, June 7, 2023 /PRNewswire/ -- Dymax, a leading manufacturer of rapid curing materials and equipment, is excited to announce the release of HLC-M-1000, the first product in its new Hybrid Light-Curable (HLC) series ...

2023-06-07 10:45 4133

Samyang Signs Partnership Agreement with Yxintent, China for Dermal Filler Lafullen®

* Yxintent will exclusively sell Lafullen® after conducting clinical trials and approval inChina, with Samyang supplying products worth KRW 100 billion over the next five years * Long-lasting biodegradable dermal filler with natural volume and long-lasting effects, proven safety and efficacy ...

2023-06-07 09:30 6079

Translumina bolsters its German presence with acquisition of Lamed GmbH

NEW DELHI and MUNICH, June 7, 2023 /PRNewswire/ -- Translumina, a global leader in interventional cardiovascular medical devices with manufacturing presence in Germany and India, today announced the acquisition of Munich-based Lamed GmbH. With this acquisition, Translumina has taken a step further...

2023-06-07 09:00 4536
1 ... 237238239240241242243 ... 380